Literature DB >> 30322986

Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003-2013).

Gina S Ogilvie1, Felicia Phan2, Heather N Pedersen2, Simon R Dobson2, Monika Naus2, Elizabeth M Saewyc2.   

Abstract

BACKGROUND: The human papillomavirus (HPV) vaccine is delivered widely through school-based immunization programs. Some groups have expressed concern that HPV vaccination programs will result in an increase in sexual risk-taking behaviours among adolescents. We aimed to evaluate population-level changes in sexual behaviours before and after implementation of the school-based HPV vaccination program in British Columbia.
METHODS: In 2008, a school-based HPV vaccination program for girls was introduced in British Columbia. Using data from the BC Adolescent Health Survey - a longitudinal provincial survey administered in schools to capture adolescent physical and emotional health indicators, we conducted a linear trend analysis on sexual health behaviours and risk factors in adolescent girls before and after the implementation of vaccination for HPV (2003, 2008 and 2013).
RESULTS: We analyzed data for 298 265 girls who self-identified as heterosexual. The proportion of girls reporting ever having sexual intercourse decreased from 21.3% (2003) to 18.3% (2013; adjusted odds ratio [OR] 0.79). Self-report of sexual intercourse before the age of 14 years decreased significantly from 2008 to 2013 (adjusted OR 0.76), as did reported substance use before intercourse (adjusted OR for 2003-2013 0.69). There was no significant change in the number of sexual partners reported (2003-2013). Between 2003 and 2013, girls' reported use of contraception and condoms increased, while pregnancy rates decreased.
INTERPRETATION: Since the implementation of school-based HPV vaccination program in BC, sexual risk behaviours reported by adolescent girls either reduced or stayed the same. These findings contribute evidence against any association between HPV vaccination and risky sexual behaviours.
© 2018 Joule Inc. or its licensors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30322986      PMCID: PMC6188947          DOI: 10.1503/cmaj.180628

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  26 in total

Review 1.  "HPV? Never heard of it!": a systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination.

Authors:  Maggie Hendry; Ruth Lewis; Alison Clements; Sarah Damery; Clare Wilkinson
Journal:  Vaccine       Date:  2013-09-09       Impact factor: 3.641

2.  Risk homeostasis theory: an overview.

Authors:  G J Wilde
Journal:  Inj Prev       Date:  1998-06       Impact factor: 2.399

3.  Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination.

Authors:  Tanya L Kowalczyk Mullins; Gregory D Zimet; Susan L Rosenthal; Charlene Morrow; Lili Ding; Marcia Shew; J Dennis Fortenberry; David I Bernstein; Jessica A Kahn
Journal:  Arch Pediatr Adolesc Med       Date:  2012-01

4.  Human papillomavirus vaccine and sexual behavior among adolescent and young women.

Authors:  Nicole C Liddon; Jami S Leichliter; Lauri E Markowitz
Journal:  Am J Prev Med       Date:  2012-01       Impact factor: 5.043

Review 5.  Sexual behaviour in context: a global perspective.

Authors:  Kaye Wellings; Martine Collumbien; Emma Slaymaker; Susheela Singh; Zoé Hodges; Dhaval Patel; Nathalie Bajos
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

Review 6.  The epidemiology of human papillomavirus infections.

Authors:  Janet G Baseman; Laura A Koutsky
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

Review 7.  Human Papillomavirus Vaccination and Sexual Disinhibition in Females: A Systematic Review.

Authors:  Purnima Madhivanan; Dudith Pierre-Victor; Soumyadeep Mukherjee; Prasad Bhoite; Brionna Powell; Naomie Jean-Baptiste; Rachel Clarke; Tenesha Avent; Karl Krupp
Journal:  Am J Prev Med       Date:  2016-04-26       Impact factor: 5.043

8.  Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis.

Authors:  Laia Bruni; Mireia Diaz; Leslie Barrionuevo-Rosas; Rolando Herrero; Freddie Bray; F Xavier Bosch; Silvia de Sanjosé; Xavier Castellsagué
Journal:  Lancet Glob Health       Date:  2016-07       Impact factor: 26.763

9.  Parental intention to have daughters receive the human papillomavirus vaccine.

Authors:  Gina S Ogilvie; Valencia P Remple; Fawziah Marra; Shelly A McNeil; Monika Naus; Karen L Pielak; Thomas G Ehlen; Simon R Dobson; Deborah M Money; David M Patrick
Journal:  CMAJ       Date:  2007-12-04       Impact factor: 8.262

10.  Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule.

Authors:  M C Tunis; S L Deeks
Journal:  Can Commun Dis Rep       Date:  2016-07-07
View more
  2 in total

1.  HPV vaccination has not increased sexual activity or accelerated sexual debut in a college-aged cohort of men and women.

Authors:  Andrew F Brouwer; Rachel L Delinger; Marisa C Eisenberg; Lora P Campredon; Heather M Walline; Thomas E Carey; Rafael Meza
Journal:  BMC Public Health       Date:  2019-06-25       Impact factor: 4.135

2.  Factors associated with interest in bacterial sexually transmitted infection vaccines at two large sexually transmitted infection clinics in British Columbia, Canada.

Authors:  Kara M Plotnikoff; Gina Suzanne Ogilvie; Laurie Smith; Robine Donken; Heather Nicole Pedersen; Hasina Samji; Troy Grennan
Journal:  Sex Transm Infect       Date:  2020-05-26       Impact factor: 3.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.